Design of Experiments Helps Increase Yield of Pharmaceutical Intermediate from 70% to 88%

Similar documents
ENHANCING SOLID-PHASE DISK EXTRACTION PERFORMANCE WITH DESIGN OF EXPERIMENTS

Use of DoE to increase process understanding of a de-bromination reaction

Using Design of Experiments to Optimize Chiral Separation

References. Continuous Manufacturing Process Development Plant Realizations. Microinnova Engineering GmbH. Europapark Allerheiligen bei Wildon

Recent Advances to Improve Chemical Development

IDENTIFICATION AND QUANTITATION OF HARD-TO-RESOLVE INDIVIDUAL COMPONENTS IN MIXTURES WITHOUT CHROMATOGRAPHY, CHEMOMETRICS, AND REFERENCE STANDARDS

Return on Investment in Discovery Chiral Separations

Manufacturing process control with PAT Substitution of off-line HPLC & GC by in-line IR spectroscopy

A Novel Software Tool for Crystallization Process Development

Perseverance. Experimentation. Knowledge.

CONTROLLED PRECIPITATION OF ACTIVE PHARMACEUTICAL INGREDIENTS EMPLOYING SUPERCRITICAL FLUIDS: SCALE-UP CONSIDERATIONS

Services in Chemistry for a Sustainable World

Pharmaceutical applications of Jacobsen HKR technology

Mirabilis 2.0. Lhasa Limited vicgm. 11 January Martin Ott

AGrignard reaction, in which a reactant, A, is coupled with phenyl magnesium chloride, is used to

ChiroSolv EnantioPrep Kits Deliver Pure Enantiomers

Best-in-class API / HPAPI / Small Molecules Custom Manufacturing

ACD/Labs Software Impurity Resolution Management. Presented by Peter Russell

CONTINUOUS FLOW CHEMISTRY (PROCESSING) FOR INTERMEDIATES AND APIs

Process Safety. Process Safety and Hazard Assessment Avoiding Incidents in the Lab and in the Plant

Industrial Applications of Microreactor Technology

HPAPI Process, Scalability & Robustness

Your Partner for Specialty Chemical Innovation & Technology

Process Design Decisions and Project Economics Prof. Dr. V. S. Moholkar Department of Chemical Engineering Indian Institute of Technology, Guwahati

How do Elements Combine to Form Compounds?

Agilent Cary 630 FTIR Spectrometer Supporting Organic Synthesis in Academic Teaching Labs

Designed polymers for purification of flavor oils

Technical Resource Package 1

Trace analysis of mesityl oxide and diacetone alcohol in pharmaceuticals by capillary gas chromatography with flame ionization detection

Sulfonation Chemistry more sustainable approaches RSC Symposium, Basel, June 1-2, Dr. Jörg Schrickel Marketing Manager Intermediates CABB AG

How to make the best out of Process R&D

Formulation Simplified: Finding the Sweet Spot via Design and Analysis of Experiments with Mixtures. Reference: Formulation Simplified

Residual Solvents in Pharmaceuticals by USP Chapter <467> Methodology

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: B01D 9/00 ( )

Intermediates. THF Solutions. Expanded Tetrahydrofuran Offer for Pharma Customers in Europe

Nano-Enabled Catalysts for the Commercially Viable Production of H 2 O 2

Continuous Manufacturing of Pharmaceuticals: Scale-up of a Hot Melt Extrusion Process

Preparation Of Aspirin Lab Report

Integrated Electricity Demand and Price Forecasting

Since 1988 High Force Research has worked with organizations operating in practically all end use sectors requiring chemical synthesis input, and

Highly automated protein formulation development: a case study

The Polyarc System Product Brochure. A Breakthrough Innovation Revolutionizing GC/FID Technology

Process Raman. Utilisation of Raman spectroscopy for primary and secondary pharmaceutical development. Allyson McIntyre Pharmaceutical Development

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

Comprehend and execute the 10 elements of effective problem

ChromegaChiral TM CSP Media and Columns

Monomer Analysis. Analysis by Gas Chromatography WASSON - ECE INSTRUMENTATION. Engineered Solutions, Guaranteed Results.

How do Elements Combine to Form Compounds?

Green Chemistry and the United States Environmental Protection Agency A Postdoc s Perspective James T. Ciszewski & Michael A.

In Situ Spectroscopy. Reaction Analysis and PAT Tools From Research to Manufacturing

Product Information. Silicon Carbide Well Plates

Introduction. New Process Engineering Laboratory Combines Advanced Equipment, Risk Management Strategy, and Quality by Design Approach

ChromegaChiral TM CSP Media and Columns

Shedding a Light on Solubility Measurement and Prediction Solubility Sub Team's Story to Date

Kalexsyn Overview Kalexsyn, Inc Campus Drive Kalamazoo, MI Phone: (269) Fax: (269)

Chemical Plant Design I Basic Concept of Process Design. Dr.Eng. Yulius Deddy Hermawan

Structural characterization begins with a purity check!

Online Reaction Monitoring of In-Process Manufacturing Samples by UPLC

10/18/2006. Biotage A Life Science Technology Company

Microreactors in Chemistry! Christina Moberg!

Process Design Decisions and Project Economics Prof. Dr. V. S. Moholkar Department of Chemical Engineering Indian Institute of Technology, Guwahati

Flk = Acy + Cy z. Discover the perfect formula Fluka Reagents. Fluka TM Accuracy Consistency AUTHENTIC

Focus Series Peptide Synthesizers

CONFOCHECK. Innovation with Integrity. Infrared Protein Analysis FT-IR

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2011/06

Chemists are from Mars, Biologists from Venus. Originally published 7th November 2006

A Holistic Approach to the Application of Model Predictive Control to Batch Reactors

High Thru-Put Zeolite M anufacture

Codex KRED Screening Kit

Chiral Quest Technology for Asymmetric Hydrogenation Applications and Gaps

High-throughput Agrochemical Formulation: Easing the Route to Commercial Manufacture

Ester Synthesis And Analysis: Aspirin and Oil of Wintergreen. Vanessa Jones November 19, 2015 Thursday 8:30 Lab Section Lab Partner: Melissa Blanco

Quality control analytical methods- Switch from HPLC to UPLC

Chemical Analysis. Low Level Oxygenates Analyzer. Trace Analysis of Oxygenates in Hydrocarbon Matrices. Gas Chromatography.

Control Strategies for Small Molecule Components of Antibody-Drug Conjugates

Improve Peak Shape and Productivity in HPLC Analysis of Pharmaceutical Compounds with Eclipse Plus C8 Columns Application

ChiroSolve Enantiomer preparation for discovery, development and manufacturing

OPTIMIZATION OF BETAINE RECOVERY IN A COUPLED LOOP MOLASSES DESUGARIZATION SEPARATOR

5072 CHEMISTRY (NEW PAPERS WITH SPA) TOPIC 1: EXPERIMENTAL CHEMISTRY 5067 CHEMISTRY (NEW PAPERS WITH PRACTICAL EXAM) TOPIC 1: EXPERIMENTAL CHEMISTRY

Automation of Routine Microplate Pipetting and Dispensing

An automated synthesis programme for drug discovery

Translational Biomarker Core

Preformulation & Solid State Chemistry Services

The effect of branched alcohol isomers on the separation of alkanes and alcohols with supercritical CO 2

Focus XC + 6 Microwave capability = Infinity Explore Infinite Possibilities. with the Infinity Microwave Peptide Synthesizer

Sample Preparation. Approaches to Automation for SPE

Fall Organic Chemistry Experiment #6 Fractional Crystallization (Resolution of Enantiomers)

Continuous Flow for APIs and Intermediates (Part 1 of 2)

Simulated Moving Bed Chromatography (SMB) F DIN EN ISO 9001 E D Q U A L T N E T Y M A N E M A G SMB. The next step in chromatography

Mechanistic Studies of Allylsilane Rearrangement

Epic Aromatic Selectivity

Advanced Flow Reactors Teaming up Chemistry and Chemical Engineer Greener Processes and Improved Economics. Frank Schmidt Sales Director

Exercise 1. Material balance HDA plant

Rosemary extract liquid

Molecular Highway TM Technology for FCC Catalysts in a Commercial Refinery

Application Note 62: Synthesis of pharmaceutical intermediate by cross-coupling with non-stabilised diazo compounds

Using a mini-gas Chromatograph (GC): Identifying Unknown Compounds

Agilent 7500a Inductively Coupled Plasma Mass Spectrometer (ICP-MS)

110 Lowell Rd Hudson, NH USA Tel:

SCPC Systems for Liquid-Liquid Extraction

Transcription:

Design of Experiments Helps Increase Yield of Pharmaceutical Intermediate from 70% to 88% Researchers at Codexis Laboratories Singapore performed a full-factorial designed experiment with 20 runs to determine the impact of four independent variables on product selectivity during a silylation reaction. The experiment revealed that the optimal combination of factors increased the selectivity of the reaction to 97% for silylation on oxygen with less than 2% each for the undesirable alternatives. Codexis researchers adjusted the factors to increase the concentration for improved throughput, resulting in a process that delivered 95% selectivity along with an 88% yield. A joint research program between Codexis and a leading pharmaceutical manufacturer addressed the production of an O-silylazetidinone, a key intermediate for the synthesis of many beta-lactam antibiotics including ertapenem, meropenem and doripenem, through the silyation of a hydroxyazetidinone. The output of the original process consisted of 70% the desired product where the silyl group is on oxygen. The output also included 11% of an isometric byproduct where the silyl group is on nitrogen and 17% of a third option where the silyl group is on both oxygen and nitrogen (i.e. bis-silylation). Codexis develops and commercializes processes to active pharmaceutical ingredients (APIs) and pharmaceutical intermediates using its proprietary biocatalytic processes. The overwhelming majority of APIs have at least one chiral center. Increased regulatory requirements for improved product purity have led to growing demand for stereochemically pure intermediates. Using proprietary biocatalysts, Codexis manufactures virtually 100% chirally pure intermediates and APIs. These are often manufactured directly at high purity, compared to low purity materials that must be isolated after being produced by traditional chemical processes. Codexis has developed an efficient and selective process for dynamic ketone reduction of a ketotester to produce a diastereomeric hydroxyketone. Conversion of the diastereomeric alcohol into the O-silylazetidinone requires additional challenging steps including the silyation of the hydroxyazetidinone. The previous pilot plant process involved treatment of a slurry of hydroxyazetidione in toluene at 25-30 o C with imidazole and then feeding in a solution of tert-butyldimethylsilyl chloride (TBSCI) in toluene. After workup and crystallization, this provided the desired product in yields of about 70%. A team of Codexis researchers including Steve Collier and Rob Wilson, set about scaling down the current process in the laboratory, addressing the selectivity and yield issues and transferring the process back to the pilot plant in as short a time as possible. The conventional approach to optimizing the factors would have been to run a series of experiments while varying a single factor, sometimes called the one-factor-at-a-time (OFAT) approach. The problem with this approach is that it does not detect interactions between factors or second order effects.

Researchers decided to use the design of experiments (DOE) method because it varies the values of all variables in parallel so it uncovers not just the main effects of each variable but also the interactions between the variables. This approach makes it possible to identify the optimal values for all variables in combination. It also requires far fewer experimental runs than the OFAT approach. Design of experiments enables chemists to efficiently define, better understand and optimize factors that are important to reaction yield and robustness, particularly where multiple parameter interactions occur, Collier, who is Director of R&D for Codexis Laboratories Singapore, said. The Codexis team uses Design-Expert software from Stat-Ease, Inc., Minneapolis, Minnesota, to design and analyze DOE experiments. Design-Expert walks users through the entire process so it enables scientists and engineers to develop their own experiments without requiring assistance from statisticians, Collier said. I am an advocate of DOE and a fan of Stat-Ease so I brought one of their instructors in to give my team a course in DOE. It was very well received and we have since utilized Design-Expert to help improve a series of important pharmaceutical processes. Factor Low level Centerpoint High level TBSCl amount 1.05 equiv 1.10 equiv 1.15 equiv Imidazole amount 1.10 equiv 1.20 equiv 1.30 equiv Substrate Concentration 0.65 M 0.868 M 1.085 M Reaction Temperature 25 o C 30 o C 35 o C Table 1: Factor values for DOE study The Codexis team selected four factors in the O-silylazetidinone process for their potential to have a significant impact on the process: equivalents of TBSCI, equivalents of base, reaction concentration and reaction temperature. The team developed a two-level factorial DOE study with 20 runs including four runs at the existing conditions in order to evaluate the robustness of the experimental data. Three responses were studied including the yield of the desired O-silyl compound, yield of the undesired N-silyl compound and yield of the undesired N,O-bis silyl compound after completion of the reaction. The experiments were centered around the existing conditions which were 1.1 equiv TBSCI, 1.2 equiv imidazole, 0.868 N concentration and 30 o C temperature. The additional runs were designed using small changes in either direction from the existing conditions. The results of each run were quantitatively analyzed using high performance liquid chromatography (HPLC). The HPLC data was analyzed using Design-Expert and models were built to determine the impact.

Figure 1: Half Normal Plot and 3-D Surface for O-Silyl Product Figure 2: Half Normal Plot and 3-D Surface for N-Silyl Product Figure 3: Half Normal Plot and 3-D Surface for N,O-Bis(silyl) Product

The DOE models showed that high levels of imidazole and high temperatures tend to increase the yield of the desired O-silyl product and that these conditions also reduce the yield of the undesired N-silyl byproduct. The power of DOE comes from its ability to identify interactions between factors, Collier said. In this case, the temperature and imidazole loading had a simple additive effect but in many other examples the interactions between factors are much more complex. Understanding these interactions, which cannot be detected without DOE, is critical to optimizing the manufacturing process. The best selectivity was provided by a run that yielded 96.6% O-silyl, 1.9% N-silyl and 1.5% N,O-bis(silyl). However, this run had a relatively low concentration so its volumetric productivity was not at optimal levels. Based on the information provided by the DOE, further experiments were performed by using the factor values that were demonstrated to provide high selectivity for O-silyl while increasing concentration in order to improve throughput. We knew if we ran dilute we could optimize selectivity but at the same time we would be reducing volumetric productivity, Collier said. Fortunately, the DOE had already shown us what levers to pull to increase selectivity. As we increased the concentration, which is negative to selectivity, we also increased the base and temperature even further than in our DOE runs to compensate. In the end we achieved the same selectivity we had observed in the DOE runs at a higher level of concentration, providing the yield that we needed for high volume manufacturing. The final conditions utilized 1.05 equiv TBSCI fed to the reactor over 1 hour, 1.3 equiv imidazole, a reaction temperature of 50 C and a concentration of 0.868 M. At the lab scale these conditions generated 96.9% O-silyl product with only 0.8% N-silyl and 0.8% N,O-bis(silyl) byproducts and 1.5% unreacted starting material. Execution of these conditions on a 10 g scale provided the desired product in 85% isolated yield with a further 8% material remaining in the mother liquors. These conditions were then successfully transferred to Codexis partner for further development and implementation at pilot scale. Scale-up proceeded smoothly and the process was run in the pilot plant using 58.2 kg of substrate providing a yield of 88.5% with an assay purity of 95.4%. The entire process described in this article from receipt of the process to tech transfer back to the pilot plant was accomplished in only four weeks. The dramatic improvements in the selectivity and yield that were achieved in this application combined with the short turnaround time demonstrates the power of carefully designed DOE studies, Collier concluded. For more information, contact: --Codexis, Inc., 200 Penobscot Drive, Redwood City, CA 94063. Ph: 650.421.8100, Email: info@codexis.com, Web site: http://codexis.com

-- Stat-Ease, Inc., 2021 E. Hennepin Avenue, Ste. 480, Minneapolis, MN 55413-2726. Ph: 612-378-9449, Fax: 612-746-2069, E-mail: info@statease.com, Web site: http://www.statease.com